NSE IPO 2026: June 15 DRHP Target, H2 Listing Timeline
A faster timetable for a long-delayed listing
National Stock Exchange (NSE) has accelerated work on its long-awaited initial public offering, nearly a decade after the listing plan first surfaced in 2016. Multiple media reports, including CNBC-TV18 and Business Standard, said the exchange has asked its bankers to expedite the filing of its draft red herring prospectus (DRHP). The near-term focus is a mid-June submission, a shift that would bring the process into a defined regulatory timetable. For market participants, the key point is that NSE’s IPO is no longer a broad intention but a process moving towards a filing date.
June 15 DRHP target and why it matters
People familiar with the matter said NSE has set June 15 as the target date to file the DRHP. The deadline is designed to ensure that the submission can be anchored to financials for the quarter ended March 2026, which were declared on Tuesday, as reported. In practice, the choice of period matters because it determines what financial information is central to the offer documents at the time they are filed. The exchange’s instruction to bankers to speed up the process signals internal alignment around that mid-June window. Reports also said that filing before the end of June could achieve the same aim of using the March 2026 quarterly financials.
SEBI review window and the listing path
After the DRHP is filed, the next step is to await final observations from the Securities and Exchange Board of India (SEBI). The review process typically takes two to three months, according to the reports. That timeline is a key determinant of when the offer could open and when the stock could list. Based on this sequence, reports indicated the listing could be on track for the second half of the calendar year.
A separate media line also suggested the listing is being targeted before December, and another report cited NSE CEO Ashish Chauhan saying the listing can take place in 8-9 months after receiving SEBI’s no-objection certificate (NoC). These statements provide a range of publicly reported expectations, but the operational milestone remains the DRHP filing.
What NSE has officially said so far
NSE’s on-record comment in response to queries focused on the regulatory clearance already received and the board’s approval for the IPO structure. The exchange said: “Pursuant to the NOC (no-objection certificate) issued by Sebi, the board approved an IPO of the company through an offer for sale on February 6, 2026. No further comments at this stage.”
This confirms two points from the company directly: SEBI’s NoC has been issued, and the board has approved an IPO via an offer for sale (OFS). Details beyond that, including filing dates and valuation, have been attributed to people familiar with the process or to media reporting.
IPO structure and valuation signals in reports
Business Standard’s reporting, repeated across other write-ups, described the IPO as being entirely through an offer for sale. Separately, reports referenced an IPO valuation range of ₹4 trillion to ₹6 trillion, framing it as an ambition of around ₹6 trillion. Another report said the issue size is likely to exceed ₹20,000 crore if the plan proceeds, positioning it as potentially the country’s largest IPO by size.
These figures are not official guidance from NSE in the text provided, but they are part of the public narrative currently shaping expectations. Investors tracking the story will likely watch whether the DRHP, once filed, corroborates the proposed structure and clarifies the final offer size.
Regulatory and compliance clean-up before the market debut
Alongside the filing push, reports indicated that NSE is settling ₹1,800 crore of regulatory cases ahead of the public listing. Another summary note said the exchange is addressing pending compliance-related matters. While the article text does not list the individual cases, the mention underscores that the IPO track is being coordinated with closure of older issues. For a market infrastructure institution, these steps are especially relevant because public market investors typically scrutinise governance and regulatory history closely.
How this affects India’s capital markets ecosystem
An NSE listing would be a landmark event for Indian market infrastructure, given the exchange’s central role in trading, clearing, and market-wide price discovery. From a market perspective, the filing and subsequent SEBI observations phase is the period when formal disclosures begin shaping investor understanding of the business, risks, and governance. The fact that the IPO is planned as an OFS, as reported, also matters for interpretation because it implies the transaction would be structured around existing shareholders selling shares rather than the company raising fresh capital.
The timetable also influences broader IPO planning in the market. A large, high-profile listing typically draws attention from institutional investors and may affect allocation preferences during the same period. But the only confirmed process steps in the provided text remain the board approval on February 6, 2026 and the intent to file the DRHP around mid-June.
Key facts at a glance
Why the mid-June filing plan is a key inflection point
The mid-June DRHP target matters because it converts a long-running listing plan into a compliance-driven schedule with defined gates: filing, SEBI observations, and then the IPO launch and listing. It also reduces ambiguity by tying the filing to a specific set of quarterly financials (March 2026). For a transaction that has been delayed for years, a credible filing date is often the most important indicator of momentum because it requires coordinated readiness across bankers, legal teams, and internal approvals.
What to watch next
The immediate trigger is whether NSE meets the June 15 DRHP filing target, or files before the end of June as the reports suggested could also work. After that, attention typically shifts to SEBI’s observation process, which the reports said usually takes two to three months. NSE has said it will not comment further at this stage, so the next set of hard information is likely to come through the prospectus filing and subsequent regulatory updates.
Frequently Asked Questions
Did your stocks survive the war?
See what broke. See what stood.
Live Q4 Earnings Tracker